These results confirmed that MCAM expression was significantly reduced in TNBC, ER+, and ER+/HER2+ breast cancer compared to the associated normal epithelium and demonstrated intra-tumoural heterogeneity in MCAM gene expression in both normal and malignant epithelial populations (Figure 7B). This evidence concerns the gene MCAM and breast carcinoma.